ArticleOPEN ACCESS

The role of dyslipidemia and statins in venous thromboembolism

Current Controlled Trials in Cardiovascular Medicine
DOI: 10.1186/CVM-2-4-165
37Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research.

Author supplied keywords

Cite

CITATION STYLE

APA

Ray, J. G., & Rosendaal, F. R. (2001). The role of dyslipidemia and statins in venous thromboembolism. Current Controlled Trials in Cardiovascular Medicine. https://doi.org/10.1186/CVM-2-4-165

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free